Bicara Therapeutics Inc (BCAX)

NASDAQ · Biotechnology

24.72
-0.22 (-0.88%)
Updated Aug 18, 5:17 PM ET
AI Rating
Sell
Overall Score
35
Trend
52
Momentum
21
Risk
28

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 19, 2026 120 sessions Aug 14, 2026

AI Analysis

Bicara Therapeutics Inc is trading at $24.72, down 0.88% on the session. The 50 day average sits at $25.45 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 41.9, which reads as weak, and MACD is bearish crossover. Volume is below average.

The nearest support is around $22.80 with resistance near $28.43, so that band frames the current range. Average daily movement is roughly $1.66, or about 6.7% of the share price, which is what any stop placement has to allow for. The overall health score of 35 out of 100 combines a trend score of 52, momentum of 21 and a risk score of 28.

Technical indicators

RSI (14)
41.9
weak
MACD
-0.461
bearish crossover
SMA 20
26.48
SMA 50
25.45
SMA 200
--
unknown
ATR (14)
1.66
avg daily range
Support
22.80
Resistance
28.43
Volume vs 20d
0.75x
below average
Volatility
70.1%
annualised
1 month
-13.75%
3 months
+5.93%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.